据实时数据显示，随着新冠肺炎疫情席卷全球，全球已有超过520万人死于该疾病，其中包括超过77.7万美国人约翰·霍普金斯大学系统科学与工程中心。
根据美国疾病控制和预防中心的数据，美国只有59.1%的人口完全接种了新冠肺炎疫苗疾病控制和预防中心。
加拿大发现第3例奥米克隆病例
加拿大卫生官员周一宣布，加拿大第三人的奥米克龙新冠肺炎变种检测呈阳性。
魁北克省卫生部长克里斯蒂安·杜贝在蒙特利尔的新闻发布会上告诉记者，魁北克省已经确认了第一例变异病毒病例。
加拿大公共卫生主任奥拉西奥·阿鲁达博士说，检测呈阳性的妇女去过尼日利亚。
官员们周日表示，此前在安大略省发现了两例变异病例。
辉瑞将要求美国食品和药物管理局授权16-17岁人群使用助推器:来源
知情人士向美国广播公司证实，辉瑞将在未来几天要求食品药品监督管理局批准为16至17岁的青少年注射新冠肺炎增强剂。
这将把助推器的使用范围从18岁以上的人扩大到16岁以上的人。
辉瑞疫苗在5月份被授权用于青少年，因此，由于对奥米克龙变体的担忧日益加剧，许多完全接种疫苗的人已经接近六个月的期限。
疾控中心加强助推器建议
疾病控制和预防中心周一加强了对成人加强剂量的建议。
史蒂夫·普弗斯特/新闻日报
随着社区成员的加入，中心的罗伯特·贝尔德得到了一剂强心剂.
之前的建议是，所有50岁及以上的成年人都应该得到一个助推器，那些18至49岁的人可能想要得到助推器。现在，疾控中心表示，所有成年人都应该在接种辉瑞或Moderna疫苗后六个月或强生疫苗注射后两个月进行强化注射。
疾控中心主任罗谢尔·瓦伦斯基说，“我强烈鼓励尚未接种疫苗的4700万成年人尽快接种疫苗，并为他们家庭中的儿童和青少年接种疫苗，因为强大的免疫力可能会预防严重疾病。”
西班牙、瑞典、捷克共和国确认第一例奥米克隆病例
据西班牙卫生部称，一名51岁的西班牙男子于11月28日从南非旅行，成为西班牙第一例奥米克龙变种确诊病例。
该男子症状轻微，正在隔离。
瑞典公共卫生管理局称，瑞典已经确定了第一例奥米克龙病例，也是最近访问过南部非洲的人。
官员称，一名接种疫苗的60岁妇女成为捷克共和国第一例确诊的奥米克隆病例。她经由南非和阿拉伯联合酋长国访问了非洲西南部的纳米比亚。官员们说，八名与受感染妇女一起旅行的人被追踪接触，现在被隔离。
这些国家也有确诊的奥米克隆病例:加拿大(2);联合王国(11);意大利(1);比利时(1);荷兰(13);德国(3);丹麦(2);葡萄牙(13);以色列(1);澳大利亚(5);香港(3);博茨瓦纳(19);和南非(具体数字不清楚)。
COVID-19 live updates: Pfizer to ask FDA to authorize boosters for people 16-17, source says
As the COVID-19 pandemic has swept the globe, more than 5.2 million people have died from the disease worldwide, including over 777,000 Americans, according to real-time data compiled byJohns Hopkins University's Center for Systems Science and Engineering.
Just 59.1% of the population in the United States is fully vaccinated against COVID-19, according to data from theCenters for Disease Control and Prevention.
3rd omicron case detected in Canada
A third person in Canada has tested positive for the omicron COVID-19 variant, health officials announced Monday.
The province of Quebec has confirmed its first case of the variant, Quebec Health Minister Christian Dube told reporters at a press conference in Montreal.
The woman who tested positive had traveled to Nigeria, said Canada Director of Public Health Dr. Horacio Arruda.
Two cases of the variant had been previously detected in Ontario, officials said Sunday.
Pfizer to ask FDA to authorize boosters for people 16-17: Source
Pfizer is going to ask the Food and Drug Administration in the coming days to authorize COVID-19 booster shots for 16- and 17-year-olds, a source familiar with the discussions confirmed to ABC News.
This would expand booster access from everyone over 18 to everyone over 16.
Pfizer vaccines were authorized for adolescents in May, so many fully vaccinated people are nearing their six-month mark amid growing concern over the omicron variant.
CDC strengthens booster recommendations
TheCenters for Disease Control and Preventionon Monday strengthenedits recommendation on booster doses for adults.
The previous recommendation was that all adults 50 and oldershouldget a booster, and those 18 to 49maywant to get boosters. Now, the CDC says all adultsshouldget a booster shot six months after their Pfizer or Moderna vaccines or two months after the Johnson & Johnson shot.
CDC director Rochelle Walensky said, "I strongly encourage the 47 million adults who are not yet vaccinated to get vaccinated as soon as possible and to vaccinate the children and teens in their families as well because strong immunity will likely prevent serious illness."
Spain, Sweden, Czech Republic confirm 1st omicron cases
A 51-year-old man in Spain who traveled from South Africa on Nov. 28 has become Spain's first confirmed case of the omicron variant, according to the health ministry.
The man has mild symptoms and is under quarantine.
Sweden has identified its first omicron case, also a person who recently visited southern Africa, the Swedish Public Health Authority said.
A vaccinated 60-year-old woman has become the first confirmed omicron case in the Czech Republic, officials said. She visited Namibia in southwest Africa via South Africa and the United Arab Emirates. Eight people who traveled with the infected woman were contact traced and are now quarantined, officials said.
These countries also have confirmed omicron cases: Canada(2); the United Kingdom (11);Italy(1); Belgium(1);the Netherlands(13); Germany(3);Denmark(2); Portugal(13);Israel(1); Australia (5); Hong Kong(3);Botswana(19); and South Africa(exact number not clear).
